Location via proxy:   [ UP ]  
[Report a bug]   [Manage cookies]                
Scribd Logo
Upload

Welcome to Scribd!

  • 758 views

    Drug Study Cefuroxime

    Uploaded by

    Dave Michael Geli
    Cefuroxime is a second-generation cephalosporin antibiotic effective for treating bone, joint, respiratory, skin, urinary, and other infections. It works by binding to bacterial cell walls, causing cell death. Common side effects include diarrhea, nausea, rash, and increased creatinine. Nurses monitor patients for hypersensitivity reactions and check kidney function during treatment.

    Copyright:

    Attribution Non-Commercial (BY-NC)
    Download as TXT, PDF, TXT or read online from Scribd

    Drug Study Cefuroxime

    Uploaded by

    Dave Michael Geli
    758 views2 pages
    Cefuroxime is a second-generation cephalosporin antibiotic effective for treating bone, joint, respiratory, skin, urinary, and other infections. It works by binding to bacterial cell walls, causing cell death. Common side effects include diarrhea, nausea, rash, and increased creatinine. Nurses monitor patients for hypersensitivity reactions and check kidney function during treatment.

    Original Description:

    Drug Study

    Copyright

    © Attribution Non-Commercial (BY-NC)

    Available Formats

    TXT, PDF, TXT or read online from Scribd

    Did you find this document useful?

    Is this content inappropriate?

    Cefuroxime is a second-generation cephalosporin antibiotic effective for treating bone, joint, respiratory, skin, urinary, and other infections. It works by binding to bacterial cell walls, causing cell death. Common side effects include diarrhea, nausea, rash, and increased creatinine. Nurses monitor patients for hypersensitivity reactions and check kidney function during treatment.

    Copyright:

    Attribution Non-Commercial (BY-NC)
    Download as TXT, PDF, TXT or read online from Scribd
    Download as txt, pdf, or txt
    758 views2 pages

    Drug Study Cefuroxime

    Uploaded by

    Dave Michael Geli
    Cefuroxime is a second-generation cephalosporin antibiotic effective for treating bone, joint, respiratory, skin, urinary, and other infections. It works by binding to bacterial cell walls, causing cell death. Common side effects include diarrhea, nausea, rash, and increased creatinine. Nurses monitor patients for hypersensitivity reactions and check kidney function during treatment.

    Copyright:

    Attribution Non-Commercial (BY-NC)
    Download as TXT, PDF, TXT or read online from Scribd
    Download as txt, pdf, or txt
    of 2

    Name of Drug Generic Name: Cefuroxime DRUG STUDY Trade Name: Ceftin Content: Classification of Drug Therapeutic: Anti-infectives

    Mechanism of Action Bind to bacterial cell wall membrane, causing cell death Indication Treatment of It is effective for the treatment of penicillinaseproduc ingNeisseria gonorrhoea(PPNG). Effectively treats bone and joint infections, bro nchitis, meningitis, gonorrhea, otitis media, pharyngitis/tonsilliti s, sinusiti s, lower respiratory tract infections, skin and soft tissue infections, urinary tract infections, and is used for surgical prophylaxis, reducing or eliminating infection. Contraindications Hypersensitivity to cephalosporins and related antibiotics; pr egnancy (category B), lactation. Side Effects GI: Diarrhea, nausea, antibioticassociated colitis. Skin: Ra sh , p ruritus, urticaria. Urogenital: Increased serum creatinine and BUN, decreased cr eatinine clearance. Hemat: Hemolytic anemia MISC: Anaphylaxis Nursing Responsibilities Before: Determine history Pharmacologic: Second Therapeutic Effects: generation Bactericidal action Cephal osporins Pregnancy Catergory B of hypersensitivity reacti ons to cephalosporins, penicillins, and history of al lergies, particularly to drugs, before therapy is initiated. Maximum Dose: Minimum Dose: Availability: Tablets: 125mg, 250mg, 500mg Powder fo r injection: 750mg, 1.5g, 7.5g Premixed containers: 750 mg/50ml, 1.5g/50ml Sourc e: Davis Drug Guide for Nurses 10th Edition Lab tests: Perform culture and sensitivity tests before initiation of therapy and periodically duri ng therapy if indicated. Therapy may be instituted pending test results. Monitor periodically BUN and creatinine clearance. During: Inspect IM and IV injection sites frequently for signs of phlebitis. Monitor for manifestations of hypersensitivity (see

    You might also like